Sean E McGuire, MD, PhD
Affiliations: | 2009- | Mol and Cell Biology/Radiation Oncology | Baylor College of Medicine/MD Anderson |
Area:
Radiation Oncology; Prostate cancer; Cancer cell metabolism; metabolic imagingWebsite:
https://faculty.mdanderson.org/profiles/sean_mcguire.htmlGoogle:
"Sean McGuire"Mean distance: (not calculated yet)
Cross-listing: MPROTree - Cell Biology Tree
Children
Sign in to add trainee| David Allen Bader | grad student | 2019 | Baylor College of Medicine (Cell Biology Tree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Nikitas J, Ong WL, Carrier N, et al. (2023) Prostate-Specific Antigen Response to Androgen Deprivation Therapy in the Neoadjuvant Setting for High-risk Prostate Adenocarcinoma (PIRANHA): Pooled Analysis of Two Randomized Clinical Trials. International Journal of Radiation Oncology, Biology, Physics |
| Vantaku V, Putluri V, Bader DA, et al. (2020) Correction: Epigenetic loss of AOX1 expression via EZH2 leads to metabolic deregulations and promotes bladder cancer progression. Oncogene |
| Boyce-Fappiano D, Bathala TK, Ye R, et al. (2020) Predictors of urinary toxicity with MRI-assisted radiosurgery for low-dose-rate prostate brachytherapy. Brachytherapy |
| Abu-Gheida I, Bathala TK, Maldonado JA, et al. (2020) Increased frequency of Mesorectal and Perirectal LN involvement in T4 Prostate Cancers. International Journal of Radiation Oncology, Biology, Physics |
| Bagley AF, Anscher MS, Choi S, et al. (2020) Association of Sociodemographic and Health-Related Factors With Receipt of Nondefinitive Therapy Among Younger Men With High-Risk Prostate Cancer. Jama Network Open. 3: e201255 |
| Bader DA, McGuire SE. (2020) Tumour metabolism and its unique properties in prostate adenocarcinoma. Nature Reviews. Urology |
| Lin C, Salzillo TC, Bader DA, et al. (2019) Prostate Cancer Energetics and Biosynthesis. Advances in Experimental Medicine and Biology. 1210: 185-237 |
| Tang C, Hoffman KE, Allen PK, et al. (2019) Contemporary prostate cancer treatment choices in multidisciplinary clinics referenced to national trends. Cancer |
| Vantaku V, Putluri V, Bader DA, et al. (2019) Epigenetic loss of AOX1 expression via EZH2 leads to metabolic deregulations and promotes bladder cancer progression. Oncogene |
| Bader DA, Hartig SM, Putluri V, et al. (2019) Mitochondrial pyruvate import is a metabolic vulnerability in androgen receptor-driven prostate cancer. Nature Metabolism. 1: 70-85 |